Back to 
BARCLAYS PLC
BARCLAYS PLC
CNSP1 quarters
Position history for BARCLAYS PLC's holdings in CNS PHARMACEUTICALS INC
Yes. Barclays holds 19 shares of CNSP (CNS Pharmaceuticals), worth $91, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$91
Current Shares
19
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CNSP: UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, VANGUARD CAPITAL MANAGEMENT LLC